1,2,3‐Triazole hybrids with anti‐HIV‐1 activity
1
WuXi AppTec Co., Ltd. Wuhan China
|
Publication type: Journal Article
Publication date: 2020-09-22
scimago Q2
wos Q2
SJR: 0.571
CiteScore: 7.0
Impact factor: 3.6
ISSN: 03656233, 15214184
PubMed ID:
32960467
Drug Discovery
Pharmaceutical Science
Abstract
The human immunodeficiency virus type 1 (HIV-1) is the major etiological agent responsible for the acquired immunodeficiency syndrome (AIDS), which is a serious infectious disease and remains one of the most prevalent problems at present. Currently, combined antiretroviral therapy is the primary modality for the treatment and management of HIV/AIDS, but the long-term use can result in major drawbacks such as the development of multidrug-resistant viruses and multiple side effects. 1,2,3-Triazole is the common framework in the development of new drugs, and its derivatives have the potential to inhibit various HIV-1 enzymes such as reverse transcriptase, integrase, and protease, consequently possessing a potential anti-HIV-1 activity. This review covers the recent advances regarding the 1,2,3-triazole hybrids with potential anti-HIV-1 activity; it focuses on the chemical structures, structure-activity relationship, and mechanisms of action, covering articles published from 2010 to 2020.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
18
20
|
|
|
Journal of Molecular Structure
19 publications, 15.08%
|
|
|
Russian Journal of Organic Chemistry
5 publications, 3.97%
|
|
|
Future Medicinal Chemistry
4 publications, 3.17%
|
|
|
Bioorganic Chemistry
4 publications, 3.17%
|
|
|
Arabian Journal of Chemistry
4 publications, 3.17%
|
|
|
ChemistrySelect
4 publications, 3.17%
|
|
|
Molecules
3 publications, 2.38%
|
|
|
International Journal of Molecular Sciences
3 publications, 2.38%
|
|
|
Pharmaceuticals
3 publications, 2.38%
|
|
|
Polycyclic Aromatic Compounds
3 publications, 2.38%
|
|
|
Russian Journal of General Chemistry
3 publications, 2.38%
|
|
|
Results in Chemistry
3 publications, 2.38%
|
|
|
Current Topics in Medicinal Chemistry
2 publications, 1.59%
|
|
|
Frontiers in Pharmacology
2 publications, 1.59%
|
|
|
Archiv der Pharmazie
2 publications, 1.59%
|
|
|
New Journal of Chemistry
2 publications, 1.59%
|
|
|
Synthetic Communications
2 publications, 1.59%
|
|
|
Heterocycles
2 publications, 1.59%
|
|
|
Chemistry and Biodiversity
2 publications, 1.59%
|
|
|
RSC Advances
2 publications, 1.59%
|
|
|
Frontiers in Chemistry
2 publications, 1.59%
|
|
|
Beilstein Journal of Organic Chemistry
1 publication, 0.79%
|
|
|
Letters in Organic Chemistry
1 publication, 0.79%
|
|
|
Letters in Drug Design and Discovery
1 publication, 0.79%
|
|
|
Organic Process Research and Development
1 publication, 0.79%
|
|
|
Antibiotics
1 publication, 0.79%
|
|
|
Research on Chemical Intermediates
1 publication, 0.79%
|
|
|
Chemistry of Natural Compounds
1 publication, 0.79%
|
|
|
Journal of Non-Crystalline Solids
1 publication, 0.79%
|
|
|
European Journal of Medicinal Chemistry
1 publication, 0.79%
|
|
|
2
4
6
8
10
12
14
16
18
20
|
Publishers
|
5
10
15
20
25
30
35
40
|
|
|
Elsevier
36 publications, 28.57%
|
|
|
Taylor & Francis
16 publications, 12.7%
|
|
|
Wiley
16 publications, 12.7%
|
|
|
MDPI
12 publications, 9.52%
|
|
|
Pleiades Publishing
9 publications, 7.14%
|
|
|
Springer Nature
7 publications, 5.56%
|
|
|
Bentham Science Publishers Ltd.
6 publications, 4.76%
|
|
|
Royal Society of Chemistry (RSC)
6 publications, 4.76%
|
|
|
American Chemical Society (ACS)
4 publications, 3.17%
|
|
|
Frontiers Media S.A.
4 publications, 3.17%
|
|
|
King Saud University
3 publications, 2.38%
|
|
|
The Japan Institute of Heterocyclic Chemistry
2 publications, 1.59%
|
|
|
Beilstein-Institut
1 publication, 0.79%
|
|
|
Hindawi Limited
1 publication, 0.79%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.79%
|
|
|
AMO Publisher
1 publication, 0.79%
|
|
|
Scientific Scholar
1 publication, 0.79%
|
|
|
5
10
15
20
25
30
35
40
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
126
Total citations:
126
Citations from 2024:
70
(55.55%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Feng L. S. et al. 1,2,3‐Triazole hybrids with anti‐HIV‐1 activity // Archiv der Pharmazie. 2020. Vol. 354. No. 1. p. 2000163.
GOST all authors (up to 50)
Copy
Feng L. S., Zheng M. J., Zhao F., Liu D. 1,2,3‐Triazole hybrids with anti‐HIV‐1 activity // Archiv der Pharmazie. 2020. Vol. 354. No. 1. p. 2000163.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1002/ardp.202000163
UR - https://doi.org/10.1002/ardp.202000163
TI - 1,2,3‐Triazole hybrids with anti‐HIV‐1 activity
T2 - Archiv der Pharmazie
AU - Feng, Lian Shun
AU - Zheng, Man Jie
AU - Zhao, Feng
AU - Liu, Duan
PY - 2020
DA - 2020/09/22
PB - Wiley
SP - 2000163
IS - 1
VL - 354
PMID - 32960467
SN - 0365-6233
SN - 1521-4184
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Feng,
author = {Lian Shun Feng and Man Jie Zheng and Feng Zhao and Duan Liu},
title = {1,2,3‐Triazole hybrids with anti‐HIV‐1 activity},
journal = {Archiv der Pharmazie},
year = {2020},
volume = {354},
publisher = {Wiley},
month = {sep},
url = {https://doi.org/10.1002/ardp.202000163},
number = {1},
pages = {2000163},
doi = {10.1002/ardp.202000163}
}
Cite this
MLA
Copy
Feng, Lian Shun, et al. “1,2,3‐Triazole hybrids with anti‐HIV‐1 activity.” Archiv der Pharmazie, vol. 354, no. 1, Sep. 2020, p. 2000163. https://doi.org/10.1002/ardp.202000163.